Clinical Trial Update: A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating different doses of RO7795081 versus placebo or semaglutide in people with Type 2 Diabetes Mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RO7795081
• semaglutide (semaglutide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: ACTIVE_NOT_RECRUITING